References
- Gnuplot version 4.2.4. http://www.gnuplot.info/. Accessed 26 December 2009.
- Toxbase 2003. http://www.toxbase.org/Poisons-Index-A-Z/B-Products/Bupropion. Accessed 23 September 2009.
- GlaxoSmithKline. Zyban (Bupropion Hydrochloride) Sustained-Release Tablets: Product Information. Welwyn: GlaxoSmithKline; 2001.
- Morazin F, Lumbroso A, Harry P, Blaise M, Turcant A, Montravers P, Gauzit R. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin Toxicol 2007; 45:794–797.
- Joint Formulary Committee. British National Formulary. 57th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2009.
- White RS, Langford JR. Sustained release bupropion: overdose and treatment. Am J Emerg Med 2002; 20:388–389.
- Aalund G, Rivera W, Velez L, Keyes D, Benitez F. A documented bupropion bezoar in the emergency department. J Toxicol Clin Toxicol 2003; 41:510.
- Findlay JW, Van Wyck Fleet J, Smith PG, Butz RF, Hinton ML, Blum MR, Schroeder DH. Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. Eur J Clin Pharmacol 1981; 21:127–135.
- Kirchheiner J, Klein C, Meineke L, Sasse J, Zanger UM, Murdter TE, Roots L, Brockmoller J. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6. Pharmacogenetics 2003; 13:619–626.
- Parkinson A, Leonard N, Draper A, Ogilvie BW. On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice. Drug Metab Rev 2006; 38:235–259.